Cytosolic tissue-type plasminogen activator (t-PA) levels in breast tumors and hormone dependence. Role of pS2.
A
A
Ruibal
A
A
Alvarez
B
B
Fernández Llana
M
M
Fernández Fernández
M C
MC
Roiz
M T
MT
Allende
D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000201:enzymology* / Q000378:metabolism; D018270:Carcinoma, Ductal, Breast / Q000201:enzymology* / Q000378:metabolism; D003600:Cytosol / Q000201:enzymology; D005260:Female; D006801:Humans; D009363:Neoplasm Proteins / Q000032:analysis; D009376:Neoplasms, Hormone-Dependent / Q000201:enzymology* / Q000378:metabolism; D011506:Proteins; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D010959:Tissue Plasminogen Activator / Q000032:analysis*; D000071163:Trefoil Factor-1; D025521:Tumor Suppressor Proteins
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D011506:Proteins; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C051838:TFF1 protein, human; D000071163:Trefoil Factor-1; D025521:Tumor Suppressor Proteins; D010959:Tissue Plasminogen Activator